Form 8-K - Current report:
SEC Accession No. 0001104659-25-020296
Filing Date
2025-03-04
Accepted
2025-03-04 16:05:29
Documents
15
Period of Report
2025-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258215d1_8k.htm   iXBRL 8-K 27127
2 EXHIBIT 99.1 tm258215d1_ex99-1.htm EX-99.1 21402
6 GRAPHIC tm258215d1_ex99-1img011.jpg GRAPHIC 49895
  Complete submission text file 0001104659-25-020296.txt   296951

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctso-20250304.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctso-20250304_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctso-20250304_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT tm258215d1_8k_htm.xml XML 3565
Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540 973-329-8885
Cytosorbents Corp (Filer) CIK: 0001175151 (see all company filings)

EIN.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36792 | Film No.: 25704233
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)